The China Pharmaceutical Ingredients Expo (API China) is the oldest exhibition in the Chinese pharmaceutical industry, having been established in 1968. The exhibits not only cover over 50,000 types of raw materials for pharmaceuticals, but also include all the excipients, functional ingredients, inner and outer packaging materials, production and testing equipment required for the production of pharmaceuticals and health products.

With the continuous implementation of generic drug consistency evaluation and the policy of joint review and approval of raw materials, auxiliaries, and packaging, it has led to pharmaceutical companies taking the initiative to improve product quality and be responsible for their own products, greatly enhancing the subjective initiative of raw material pharmaceutical companies.

The China International Pharmaceutical Ingredients Expo (API China) has become an efficient one-stop industry platform for tens of thousands of domestic and foreign pharmaceutical and health product manufacturers, providing an excellent opportunity for overseas pharmaceutical colleagues to fully understand the development trends of the Chinese pharmaceutical and health product industries, make new friends in the industry, and discover new business opportunities. (The content of this article belongs exclusively to JuZhan Network, and unauthorized forwarding is prohibited.)

The market for the China International Pharmaceutical Ingredients Expo (API China) will undoubtedly experience new vitality with the implementation of the joint review and approval system. Leading traditional strengths and latest research and development of new varieties will gather under the banner of Chinese pharmaceutical industry giants such as Sinopharm Group, Tianyao Group, Shanghai Pharmaceutical Group, Qilu Pharmaceutical, Northeast Pharmaceutical, Shandong Xinhua, Livzon Group, HuaHai Pharmaceutical, HaiZheng Pharmaceutical, ChuangNuo Pharmaceutical, HengXin Pharmaceutical, Disa Pharmaceutical, and Erkang Pharmaceutical.